Most Americans have never heard of magnetic resonance guided focused ultrasound (MRgFUS), yet it is a technology that promises to revolutionize medical care around the world.
“We’re at the same point with focused ultrasound as we were with diagnostic MRIs several decades ago,” says Neal F. Kassell, M.D., a professor of neurosurgery at the University of [...]

Researchers at the Mayo Clinic campus in Florida and their collaborators worldwide have discovered that a single gene promotes development of essential tremor in some patients and Parkinson’s disease in others. These are two common but distinct neurological disorders. Notably, patients with essential tremor shake when they move, and Parkinson’s disease patients shake when they [...]

GE Healthcare announced that the Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for DaTSCAN (Ioflupane I123 Injection) for priority review. DaTSCAN is a radiopharmaceutical agent containing Ioflupane (¹²³I) in development for a proposed indication of the detection of loss of functional nigrostraiatal dopaminergic neurons by single photon emission computed tomography [...]

The primary objective of this workshop was to develop a comprehensive R&D roadmap that would fast-track the use of focused ultrasound technology to treat a variety of brain disorders including benign and malignant tumors, Parkinson’s disease and essential tremor, stroke, and epilepsy.

Dystonia is a very complex, highly variable neurological movement disorder characterized by involuntary muscle contractions. As many as 250,000 people in the United States have dystonia, making it the third most common movement disorder behind essential tremor and Parkinson’s disease. The prevalence of generalized primary dystonia is estimated at 34 in 100,000 people worldwide, but [...]